Read Full Text: Multiple system atrophy: Insights into a rare and debilitating movement disorder (This is a paid article, but we thought it was still important to cover.)
Journal: Nature Reviews Neurology
Year Published: 2017
Ranked 20th on our 2016-2021 list of the 100 Most Influential OT Related Articles
This week’s article tackles a challenging diagnosis: multiple system atrophy (MSA).
MSA is a rare and aggressive type of terminal movement disorder. These patients face many challenges, including autonomic dysfunction and progressive motor system degeneration.
In this article, you’ll find a great condition-specific assessment, as well as some recommendations for supporting patients and families as they come to terms with an MSA diagnosis.
Perhaps most importantly, you’ll be reminded of the sobering reality that there is no cure for MSA. This means occupational therapy is one of the few options available to help patients navigate increasing challenges with dignity. By better understanding this rare condition, we can walk alongside patients and families, providing support and care when they need it most.
Let’s dive in.
What was the intent of this paper?
This evidence review provides a substantial update regarding what we know (and don’t know) about multiple system atrophy (MSA).
It is an extremely useful read for anyone looking to understand this diagnosis on a deeper level than what a standard Google search would yield. There is a lot of hardcore science in this paper, so I’ve done my best to pull the most salient points relevant to our work as OTs.
What is multiple system atrophy (MSA)?
Multiple system atrophy (MSA) is an adult-onset movement disorder with an aggressive clinical course. MSA patients can expect to live about 9 years from the point of symptom emergence.
The first symptoms of MSA usually occur when patients are in their 50s. Multiple neuronal pathways degenerate over the course of the disease, which creates a complex and multifaceted clinical picture. (Hence the name multiple system atrophy.)
Autonomic dysfunction is a hallmark of this disorder, as is motor system degeneration. The types of motor degeneration are divided into two main subtypes:
- MSA with predominant parkinsonism (MSA-P) subtype
- MSA with predominant cerebellar ataxia (MSA-C) subtype
Symptoms of MSA
The authors state that “disability develops relentlessly.” The combination of symptoms is varied and evolves over time. But, below are some of the most common clinical characteristics.
Autonomic dysfunction
Lightheadedness and urinary incontinence are some of the first clinical signs experienced by patients. Autonomic dysfunction can present in a wide variety of ways, but two hallmarks of MSA include:
Orthostatic hypotension
- Recurrent syncope
- Dizziness
- Nausea
- General weakness
- Tremulousness
- Headache
- Pain, often in the nuchal “neck region,” particularly coat hanger pain
Urogenital dysfunction
- Erectile dysfunction
- Reduced genital sensitivity
- Urinary urgency and frequency
- Incomplete bladder emptying
- Urinary incontinence
Parkinsonism symptoms
- Akinetic-rigid syndrome
- Lack of movement and/or slow movement
- Muscle stiffness
- Resistance to passive movement
- Orofacial dystonia
- Quivering, high-pitched dysarthria
Cerebellar ataxia symptoms
- Gait and limb ataxia
- Scanning dysarthria (also known as explosive speech)
- Cerebellar oculomotor disturbances (gaze-evoked nystagmus and hypometric saccades)
Other MSA related symptoms
- Sialorrhea (drooling or excessive salivation)
- Camptocormia (also known as bent spine syndrome)
- Pisa syndrome (causes patient to lean to one side: think leaning tower of Pisa)
- Antecollis (forward flexion of neck)
- Stridor (strained, high-pitched, harsh respiratory sound)
- REM sleep behavior disorder (RBD)
Cause of MSA
Our understanding of what causes MSA is incomplete, but the evidence seems to suggest the dysfunction of a protein called alpha-synuclein.
Dysfunction of the alpha-synuclein protein also seems to be a component of Parkinson’s disease and dementia with Lewy bodies, which may explain the similarity in these three diagnoses.
Diagnosis of MSA
Diagnosis is tricky. There are no lab tests or imaging that can confirm MSA, so it’s often diagnosed based on clinical presentation.
The clinical diagnosis of probable MSA requires the following features:
- Sporadic, progressive, adult onset (>30 years old) of symptoms
- Autonomic failure involving either urinary incontinence or an orthostatic blood pressure decrease within three minutes of standing (by ≥30 mmHg systolic or ≥15 mmHg diastolic)
- Either poorly levodopa-responsive parkinsonism or a cerebellar syndrome
One of the biggest challenges of diagnosing MSA is ruling out Parkinson’s disease and Lewy body dementia. There is significant overlap in symptoms, which makes accurate diagnosis challenging.
Assessment of MSA
The article mentioned one assessment tool that is specific to MSA. This assessment might be a helpful tool for you, considering the many systems impacted by MSA:
Symptomatic treatment of MSA
There are no therapies that change the relentless course of MSA. So, as a therapist, your focus is on helping patients manage their symptoms.
The article specifically mentions occupational therapy’s role in preventing falls, and the authors discuss how patients can better manage orthostatic hypotension.
** Preventing falls**
Occupational therapy is mentioned (along with PT and walking aids) as the best treatment option to prevent falls. The article cites this older, but very specific, article: Occupational therapy in multiple system atrophy: a pilot randomized controlled trial.
Managing orthostatic hypotension
It is widely accepted that non-pharmacological should be the first line of treatment for autonomic failure in MSA.
Here’s the specifics mentioned by the article:
- Patient education regarding physical countermeasures to orthostatic hypotension
- Large meals should be avoided
- Patients should adhere to a high-salt diet and ensure sufficient fluid intake
- Venous compression by use of stockings and binders may be helpful
- Nighttime head-up tilt may alleviate hypotension in the early morning
The article does not mention this, but I did find a guide for occupational therapists treating MSA. This guide was put together by the MSA Trust, which is based out of the UK.
Connecting with others with MSA
The article ends with a description of how important it is to get all hands on deck. There is a clear need for a globally coordinated effort to research MSA. The authors did also mention specific charities that can serve as a connecting point for MSA patients.
- The MSA Coalition (US-based)
- The MSA Trust (UK and Ireland)
- MSA Down Under (Australia and New Zealand)
Here’s a video from the MSA Coalition that really helped me put a face to the diagnosis:
Takeaways for OT practitioners:
(These are my own personal takeaways and were not mentioned specifically in the research.)
1. This article provides concrete ways to support those with MSA.
You might only see one or two patients with MSA across all the years you practice. So, between the infrequency of seeing these patients and the cascading number of difficulties such patients face, it might feel difficult to know where to start.
But, this article really showcases the importance of what you have to offer. Strategies for managing autonomic dysfunction should certainly be considered, as should fall prevention and recovery. And, as always, it is of the utmost importance to listen to the specific needs of each patient.
2. If you treat patients with POTS, dementia, or Parkinson’s disease, it’s crucial to be aware of MSA.
If a patient’s current diagnosis does not seem to fully match their symptoms, it’s critical that you understand similar and/or related diagnoses. You might need to talk to your team about deeper exploration of symptoms, especially as new ones emerge.
And, from a broad perspective, I think it is important to watch how our understanding of these related conditions develops. Personally, I feel hopeful that advances in the upcoming decades will provide new treatment options—not just for mainstream conditions, but also for their more rare counterparts.
Here’s the full APA citation for this article:
Krismer F, Wenning GK. Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol. 2017 Apr;13(4):232-243. doi: 10.1038/nrneurol.2017.26. Epub 2017 Mar 17. PMID: 28303913.